Last updated on October 2017

A Phase 2 Multicenter Study Evaluating Subjects With Relapsed/Refractory Mantle Cell Lymphoma


Brief description of study

Study KTE-C19-102 is a phase 2, multicenter, open-label study evaluating the efficacy of KTE-C19 in subjects with Relapsed/Refractory MCL

Clinical Study Identifier: NCT02601313

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Javier Munoz, MD, FACP

Banner MD Anderson
Gilbert, AZ United States
  Connect »

Hormoz Mirshkarlo

City of Hope
Duarte, CA United States
  Connect »

Medical Information

UC San Diego Moores Cancer Center
La Jolla, CA United States
  Connect »

David Miklos, MD, PhD

Stanford University
Stanford, CA United States
  Connect »

Juli Murphy

Sarah Cannon
Denver, CO United States
  Connect »

Amer Beitinjaneh

University of Miami
Miami, FL United States
  Connect »

Matthew Scott

H Lee Moffitt Cancer Center
Tampa, FL United States
  Connect »

Neera Jagirdar

Winship Cancer Institute of Emory University
Atlanta, GA United States
  Connect »

Ray Robinson

University of Chicago
Chicago, IL United States
  Connect »

Michael Rocchio

Dana-Farber Cancer Institute
Boston, MA United States
  Connect »

Marie Ventimiglia

Barbara Ann Karmanos Cancer Institute
Detroit, MI United States
  Connect »

Kelly Azzollini

Hackensack University Medical Center
Hackensack, NJ United States
  Connect »

Frances Batarse

University of Rochester Medical Center
Rochester, NY United States
  Connect »

Donna Abounader

Cleveland Clinic Foundation
Cleveland, OH United States
  Connect »

Laurie Delanty

Robert W. Franz Cancer Research Center
Portland, OR United States
  Connect »

Christy Riggins

Sarah Cannon Research Institute
Nashville, TN United States
  Connect »

Sandy Li

Baylor Charles A. Sammons Cancer Center
Dallas, TX United States
  Connect »

Michael (Luhua) Wang, MD

University of Texas MD Anderson Cancer Center
Houston, TX United States
  Connect »

JoDell McCracken

Methodist Hospital
San Antonio, TX United States
  Connect »

Melinh Jones-Nozynski

Swedish Cancer Institute
Seattle, WA United States
  Connect »